Actuate Therapeutics Inc
ACTU
NASDAQ
Biotechnology
$1.01
USD
+0.03 (+3.58%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $24.40M
Volume 109.6K
Price Target
$6.00 – $6.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $6.00 and a min estimate of $6.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$6.00
-$9.0 vs prior
Implied Upside
+494.1%
-891.1% vs prior
Analyst Covering
1
Unchanged vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
50%
A mix of recent and older ratings shape this consensus
Analyst Agreement
High
Targets are closely clustered - analysts largely agree
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Michael G. King Jr. | Rodman & Renshaw | Buy | Initiated | 2 weeks ago | Plus | Plus | Plus |
Frequently Asked Questions
